Patients with LEOPARD syndrome-related SHP2 mutations exhibit resistance to diet-induced obesity, an improved overall metabolic profile, and insulin hypersensitivity102. This evidence concerns the gene PTPN11 and obesity due to melanocortin 4 receptor deficiency.